Article
Design of Broadly Cross-Reactive M Protein–Based Group A Streptococcal Vaccines
1 Aug 2021
Abstract excerpt
Group A streptococcal infections are a significant cause of global morbidity and mortality. A leading vaccine candidate is the surface M protein, a major virulence determinant and protective Ag. One obstacle to the development of M protein-based vaccines is the >200 different M types defined by the N-terminal sequences that contain protective epitopes. Despite sequence variability, M proteins share coiled-coil...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
